U.S. Stock News

NYSE:GWRE
NYSE:GWRESoftware

July 2026's Top Stocks Believed To Be Trading Below Intrinsic Value

Over the last 7 days, the United States market has experienced a 1.5% decline, although it remains up by 16% over the past year with earnings forecasted to grow by 17% annually. In this environment, identifying stocks that are believed to be trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on undervaluation amidst broader market growth trends.
NasdaqGS:UXIN
NasdaqGS:UXINSpecialty Retail

3 Growth Stocks With High Insider Ownership And Up To 34% Revenue Growth

Over the last 7 days, the United States market has experienced a 1.5% drop, yet it remains up by 16% over the past year with earnings forecasted to grow by 17% annually. In such an environment, growth stocks with high insider ownership can be particularly appealing as they often signal confidence from those closest to the company's operations and potential for significant revenue expansion.
NasdaqGM:CMRC
NasdaqGM:CMRCIT

Promising Penny Stocks To Consider In July 2026

Over the last 7 days, the United States market has dropped 1.5%, yet it remains up 16% over the past year, with earnings anticipated to grow by 17% per annum in the coming years. In such a landscape, identifying stocks with strong financials is crucial for investors seeking opportunities beyond traditional large-cap investments. Penny stocks, despite their somewhat outdated moniker, continue to intrigue investors due to their potential for value and growth; we'll explore several that stand...
NYSE:BAP
NYSE:BAPBanks

3 Reliable Dividend Stocks To Consider With Up To 6.2% Yield

Over the last 7 days, the United States market has experienced a 1.5% drop, yet it has risen by 16% over the past year with earnings forecast to grow by 17% annually. In this dynamic environment, reliable dividend stocks can offer investors a steady income stream and potential for capital appreciation.
NYSE:CHD
NYSE:CHDHousehold Products

3 Consumer Staples Stocks For Defensive Dividend Investors

Consumer staples often sit quietly in portfolios while headlines focus on airlines, tech giants, and swings in oil prices. Yet when companies like Coca-Cola beat earnings expectations and raise their outlook, it can draw attention back to dependable dividend payers. With recent results from Boeing, JetBlue, UPS, and sharp moves in Brent oil creating fresh cross-currents for markets, this article looks at three large, established consumer staples stocks from our defensive dividend screener...
NYSE:CNC
NYSE:CNCHealthcare

Centene (CNC) Stock Shrugs Off EPS Surge As Medicaid Risks Linger

Centene stock barely flinched after earnings, slipping only 0.3% to about US$63.90, even though the headline numbers packed far more punch than that move suggests. The insurer lifted full year adjusted earnings per share guidance to more than US$4.80 and posted Q2 adjusted EPS of US$2.51, powered in part by risk adjustment settlements. For a company still wrestling with unprofitable trailing twelve month results, that kind of earnings power and guidance reset is the real story. The modest...
NYSE:XYL
NYSE:XYLMachinery

Xylem (XYL) Stock Rallies As Record Margins Power Profit Growth

Xylem shares opened the morning after earnings up about 4% at US$124.97, a strong move for a steady water technology stock that usually trades on long contracts rather than headlines. The market is reacting to one clear message: profitability is the story this quarter. Record quarterly earnings per share of US$1.46 and an adjusted EBITDA margin of 23.3% put the focus firmly on margins rather than modest top line growth. For investors thinking beyond today’s bounce, the question now is how...
NYSE:ABBV
NYSE:ABBVBiotechs

The Bull Case For AbbVie (ABBV) Could Change Following EU Approval Of Rinvoq For Vitiligo

AbbVie recently announced that the European Commission approved RINVOQ (upadacitinib, 15 mg once daily) as the first systemic therapy in the EU for non-segmental vitiligo in patients 12 years and older who are candidates for systemic treatment. This decision expands AbbVie’s immunology footprint into an area of high unmet need, potentially enhancing the clinical and commercial profile of RINVOQ across dermatology. We’ll now examine how RINVOQ’s new European non-segmental vitiligo approval...
NYSE:UNH
NYSE:UNHHealthcare

UnitedHealth (UNH) Stock Could Be A Bargain On Earnings Yet Fully Priced After A 69% Run

UnitedHealth Group has delivered a strong 68.6% return over the past year, yet its valuation checks point to a more mixed picture rather than a clear bargain or an obviously stretched stock. Over the last 12 months, the stock is up 68.6%, which puts recent buyers in a comfortable position and raises the bar for what counts as good value from here. Recent coverage has highlighted improved profitability and operational efficiencies as potential supports for earnings, while ongoing shifts in...
NasdaqGS:LILA
NasdaqGS:LILATelecom

Liberty Latin America (LILA) Stock Looks Cheap As It Sells Peru Stake

Liberty Latin America stock has delivered a 24.0% gain over the past year but is still down 37.7% over five years, which raises the question of whether the recent recovery is finally bringing the share price closer to what its fundamentals suggest. Over the last five years the stock has declined 37.7%, which indicates long term holders have not yet recovered from earlier share price weakness. The recent agreement to sell its stake in Peru based WOW Tel S.A.C. can help Liberty Latin America...
NYSE:LUV
NYSE:LUVAirlines

What Southwest Airlines (LUV)'s Profit Rebound and Completed Buybacks Means For Shareholders

In the second quarter of 2026, Southwest Airlines Co. reported revenue of US$8,432 million and net income of US$233 million, with both figures higher than a year earlier, alongside improved earnings per share. Over the first half of 2026, Southwest’s net income rose to US$460 million from US$64 million, highlighting a much stronger earnings profile while the company simultaneously completed a multi‑year share repurchase program totaling 37,538,504 shares for US$1,550.06 million. We’ll now...
NYSE:BE
NYSE:BEElectrical

Bloom Energy (BE) Is Down 26.3% After Record Q2 And Higher 2026 Outlook - Has The Bull Case Changed?

Bloom Energy reported record second-quarter 2026 results, with revenue rising to about US$1.07 billion from US$401.24 million a year earlier and net income improving to US$196.29 million, while also raising its full-year 2026 revenue outlook to US$3.9 billion–US$4.2 billion. The company underscored rapidly growing demand from AI and hyperscale data centers and expanded its Brookfield financing framework to up to US$25.00 billion, highlighting how large capital commitments are supporting its...
NYSE:BWXT
NYSE:BWXTAerospace & Defense

How Investors Are Reacting To BWX Technologies (BWXT) Expanding Nuclear Capacity And Rising Free Cash Flow

In recent months, BWX Technologies has expanded its precision nuclear manufacturing capacity through acquisition while reporting rapidly rising year-over-year sales and improved free cash flow margins, supported by growing AI-related demand for nuclear power. This combination of stronger operating cash generation and a larger production footprint suggests BWX Technologies may now have greater flexibility to fund future nuclear-related projects or shareholder returns. We’ll now examine how...